艾格眼科 is a Sino-foreign joint‑venture ophthalmology hospital group that operates a large network of specialty eye hospitals in Wuhan, Hubei and other core cities in Central China. The group provides full‑spectrum ophthalmic medical services for all ages, supported by an expert medical team and advanced diagnostic and surgical equipment. It has delivered over 3 million patient visits and performed more than 200,000 surgeries to date, and reports annual growth above 40%. The company positions quality care and a ‘professional is best’ operating philosophy at its core. Current plans call for continued expansion across Hubei and Central China and phased geographic growth into South, East and Southwest China, targeting 30 boutique hospitals by 2022.

Total raised

$40M

Funding rounds

1

Latest round

Series B

Latest activity

Mar 2018